July 2020

Triple negative breast cancer meets its match

BBOX1 enzyme could serve as a drug target for the deadly subset of breast cancer.

More About this Research
Drs. Lianxin Hu, Qing Zhang, and Haibiao Xie

July 2020

UTSW researchers uncover new vulnerability in kidney cancer

In their investigation of the most common type of kidney cancer, called clear cell renal cell carcinoma (ccRCC), Qing Zhang, Ph.D., and his colleagues identified a possible way to treat tumors while sparing nearby healthy tissue.

Read the Feature